• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635TU70020
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Blood Loss (2597)
Event Date 12/02/2019
Event Type  Injury  
Event Description
Option study.It was reported that there was a hematoma and bleeding that occurred.On (b)(6) 2019 a left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 35mm watchman flx laa closure device & delivery system (wds) were used.The patient was ablated using the pulmonary vein isolation ablation technique.During the procedure, heparin, apixaban and prophylactic antibiotics were administered.The patient underwent successful placement of a 35 mm watchman flx device with a complete laa seal and deployed device diameter of 26mm.Post procedure, the patients blood pressure dropped to 63/42 and a large left groin hematoma was also noted.The hematoma was treated with compression and hospitalization was prolonged.Ct abdomen and pelvis revealed left sided retroperitoneal bleed ranging from 10.2 x 3.6 x 5.5 cm.The retroperitoneal bleed was complicated due to watchman device placement.At the time of the event, the patient was on apixaban and aspirin which were temporarily withheld.The patient was transfused with 2 units of prbc and 2.5l of fluid were given.On (b)(6) 2019, the patient was re-started on anticoagulant medications.On (b)(6) 2019, the patient was discharged home on apixaban and aspirin.On (b)(6) 2019, the bleeding was considered recovered/resolved.On (b)(6) 2020 the hematoma event was considered recovered/resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN TRUSEAL ACCESS SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key9849875
MDR Text Key184050049
Report Number2134265-2020-03387
Device Sequence Number1
Product Code DQY
UDI-Device Identifier08714729965718
UDI-Public08714729965718
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2022
Device Model NumberM635TU70020
Device Catalogue NumberM635TU70020
Device Lot Number0024270508
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/24/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/15/2019
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
-
-